Valuation: Ono Pharmaceutical Co., Ltd.

Market Cap 1,177B 7.47B 6.68B 6.18B 5.6B 10.47B 711B 10.65B 74.38B 29.42B 372B 28.04B 27.44B P/E 2027 *
15.6x
P/E 2028 * 18.3x
Enterprise Value 975B 6.19B 5.53B 5.12B 4.64B 8.68B 589B 8.82B 61.61B 24.37B 308B 23.23B 22.73B EV / Sales 2027 *
2.12x
EV / Sales 2028 * 2.06x
Free-Float
82.24%
Yield 2027 *
3.19%
Yield 2028 * 3.19%
1 day+0.24%
1 week+3.75%
Current month+6.75%
1 month+2.58%
3 months+2.87%
6 months+6.60%
Current year+15.30%
1 week 2,424
Extreme 2424
2,565.5
1 month 2,230.5
Extreme 2230.5
2,565.5
Current year 2,114.5
Extreme 2114.5
2,674.5
1 year 1,764.5
Extreme 1764.5
2,674.5
3 years 1,474
Extreme 1474
2,849
5 years 1,474
Extreme 1474
3,990
10 years 1,474
Extreme 1474
3,990
Manager TitleAgeSince
Chief Executive Officer 68 31/03/2024
Director of Finance/CFO - 31/03/2026
President 57 31/03/2024
Director TitleAgeSince
Chairman 68 31/03/2024
Director/Board Member 57 31/05/2020
Director/Board Member 77 25/06/2018
Change 5-day change 1-year change 3-year change Capi.($)
+0.24%+3.75%+36.44%-3.51% 7.49B
+0.15%+3.16%+54.84%+125.24% 1,135B
+0.77%+4.64%+39.55%+78.23% 635B
-0.05%+1.02%+25.22%+96.66% 505B
+1.43%+4.31%+48.28%+67.12% 378B
-3.45%-2.12%+59.75%+33.19% 358B
-0.41%+2.64%+23.58%+49.82% 295B
+0.23%+3.66%+2.45%+23.69% 266B
+0.66%+3.95%+51.72%+63.79% 237B
+1.41%+3.16%+31.08%+101.16% 193B
Average +0.11%+1.79%+37.29%+63.54% 401.11B
Weighted average by Cap. +0.07%+1.63%+41.37%+83.17%

Financials

2027 *2028 *
Net sales 461B 2.93B 2.62B 2.42B 2.19B 4.1B 278B 4.17B 29.12B 11.52B 146B 10.98B 10.74B 449B 2.85B 2.55B 2.36B 2.13B 3.99B 271B 4.06B 28.36B 11.22B 142B 10.69B 10.46B
Net income 75.72B 481M 430M 398M 360M 674M 45.72B 685M 4.78B 1.89B 23.92B 1.8B 1.77B 64.47B 409M 366M 338M 306M 574M 38.93B 583M 4.07B 1.61B 20.36B 1.54B 1.5B
Net Debt -202B -1.28B -1.15B -1.06B -961M -1.8B -122B -1.83B -12.77B -5.05B -63.82B -4.81B -4.71B -251B -1.59B -1.43B -1.32B -1.19B -2.24B -152B -2.27B -15.87B -6.28B -79.34B -5.98B -5.86B
Projected Income Statement - Annual - Ono Pharmaceutical Co., Ltd.
Logo Ono Pharmaceutical Co., Ltd.
Ono Pharmaceutical Co Ltd is a Japan-based company primarily engaged in the pharmaceutical business. The Company is engaged in the manufacture and sale of prescription and over-the-counter drugs. The Company has been particularly focused on research and development of prescription drugs, positioning them as its core business. The Company’s products include injectables, oral medications, and patches.
Employees
4,206
Date Price Change Volume
26/10/26 JP¥2,505.00 +0.24% 1,173,500
23/10/26 JP¥2,499.00 -0.70% 1,575,600
22/10/26 JP¥2,516.50 +0.54% 1,322,200
21/10/26 JP¥2,503.00 +0.87% 1,841,400
20/10/26 JP¥2,481.50 +1.89% 1,701,000
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - Ono Pharmaceutical Co., Ltd.
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
12
Last Close Price
2,505.00JPY
Average target price
2,520.83JPY
Spread / Average Target
+0.63%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Ono Pharmaceutical Co., Ltd.
  1. Stock Market
  2. Stocks
  3. 4528 Stock